<DOC>
	<DOCNO>NCT00086268</DOCNO>
	<brief_summary>This study evaluate effect investigational drug combination chemotherapy patient stage IIIB/IV non-small cell lung cancer . This study measure effect combination progression lung cancer , cancer response treatment , development cancer-related bone lesion .</brief_summary>
	<brief_title>Non-small Cell Lung Cancer Study US75 ( Z-PACT )</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Zoledronic acid</mesh_term>
	<criteria>Male Female patient least 18 year old Patients diagnose nonsmall cell lung cancer treat surgery Women must pregnant attempt become pregnant Able willing sign inform consent Patients cancer spread bone Patients cancer spread brain receive treatment Patients kidney disease Patients treat investigational drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>lung cancer</keyword>
	<keyword>ZPACT</keyword>
	<keyword>US75</keyword>
	<keyword>Bone Metastases</keyword>
</DOC>